U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07185724) titled 'Ketorolac Use and Fresh Embryo Transfer Outcomes' on Sept. 10.
Brief Summary: Ketorolac is a medication often used to relieve pain after surgery. In the past, infertility doctors have been cautious about using ketorolac after egg retrieval for patients planning a fresh embryo transfer (usually done 5 days later). The concern was that ketorolac might increase the risk of bleeding or reduce the chances of the embryo implanting in the uterus. This concern comes from how ketorolac works-it blocks certain chemicals in the body (like prostaglandins and thromboxane) that help with blood clotting and play a role in early pregnancy.
Howeve...